A Winston & Strawn associate opened the door. Now Katten’s CEO is speaking up.
Continue readingMore Lawyers Are Addressing Twin Stigmas of Mental Health and Psychedelics | The American Lawyer
What to Expect in Neuroscience, Genetics, Longevity, Biotech, and Psychedelics in 2022 – NEO.LIFE
We ask the experts what’s coming in the next 12 months.
Continue readingPsychedelics & MDMA are finally being legalised for mental health therapy
One psychologist called it “the greatest leap forward in mental health care since the invention of psychotherapy.”
Continue readingEleusis joins cooled-off SPAC market with $288M to bankroll psychedelic-based depression drug
With investor interest in psychedelics heating up, Eleusis joins the relatively quiet SPAC market in a deal that gives the biotech $288 million to test a psilocybin-based treatment for depression. The proceeds will also bankroll an expansion of subsidiary Andala’s drug therapy clinics.
Continue reading2022 Will Be A Big Year For Psychedelics And 3D Printing – ValueWalk
Reilly: Lastly, do you think this will be a big year for 3D printing?
Continue readingNucleus, a Data-Driven Psychedelics Platform, Begins to Orbit the Mental Health Crisis; Logan Lenz to Captain the Ship
/PRNewswire/ — Nucleus, a South Florida startup focused on mental health data and technologies, today announced its launch. The company, which is wholly owned…
Continue readingNucleus, a Data-Driven Psychedelics Platform, Begins to Orbit the Mental Health Crisis; Logan Lenz to Captain the Ship
FORT LAUDERDALE, Fla., Jan. 19, 2022 /PRNewswire/ — Nucleus, a South Florida startup focused on mental health data and technologies, today announced its launch. The company, which is wholly owned
Continue readingThe Top Five Psychedelic Companies to Watch in 2022
The year 2021 has not been kind to the psychedelics industry. The stock performances of the 60 publicly traded psychedelics companies on the Psychedelic Stock Index have been trending steadily downward since February 22, 2021, to their lowest point since the index began on June 1, 2020. The pandemic has definitely affected psychedelic business development. […]
Continue readingLexston Life Sciences aims to bring psychedelics to those in need – Think Local
Lexston Life Sciences has been in the cannabis research industry for nearly a decade.
Continue readingPsygen Receives Dealer’s Licence To Become Canada’s First Dedicated Psychedelics Manufacturing Facility
Psygen Labs, a privately held active pharmaceutical ingredient manufacturer based in Calgary, Alberta, has been issued a dealer’s licence by Health Canada.
Continue reading